The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Ortabaeva D.R.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiology Center of the Ministry of Health of Russia

Zikiryakhodzhaev A.D.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Russia;
Peoples’ Friendship University of Russia

Rasskazova E.A.

P.A. Herzen Moscow Oncology Research Institute - Branch of the National Medical Radiology Research Center of the Ministry of Health of the Russia

Saribekyan E.K.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiology Center of the Ministry of Health of Russia

Khmelevsky E.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Treatment option for Stage 1 breast cancer in patients over 65 years of age

Authors:

Ortabaeva D.R., Zikiryakhodzhaev A.D., Rasskazova E.A., Saribekyan E.K., Khmelevsky E.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2021;10(5): 55‑60

DOI: 10.17116/onkolog20211005155

Read: 5040 times

Download PDF (RU)
Contact the author
Table of contents

TREATMENT OPTION FOR STAGE 1 BREAST CANCER IN PATIENTS OVER 65 YEARS OF AGE
TREATMENT OPTION FOR STAGE 1 BREAST CANCER IN PATIENTS OVER 65 YEARS OF AGE

To cite this article:

Ortabaeva DR, Zikiryakhodzhaev AD, Rasskazova EA, Saribekyan EK, Khmelevsky EV. Treatment option for Stage 1 breast cancer in patients over 65 years of age. P.A. Herzen Journal of Oncology. 2021;10(5):55‑60. (In Russ.)
https://doi.org/10.17116/onkolog20211005155

Подписка 2026 Онкология. Журнал им. П.А. Герцена (P.A. Herzen Journal of Oncology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Capsular contracture after reco­nstructive plastic surgery for breast cancer. P.A. Herzen Journal of Onco­logy. 2024;(6):78-83
Neoadjuvant drug therapy and onco­logical outcomes in patients with stage I–II breast cancer. P.A. Herzen Journal of Onco­logy. 2025;(1):5-12
Free nipple-areolar complex grafting combined with reco­nstruction for unavoidable mastectomy. Plastic Surgery and Aesthetic Medi­cine. 2024;(4):60-64
Breast reco­nstruction after single-stage auto­logous reco­nstruction and subsequent flap lipo­necrosis. Plastic Surgery and Aesthetic Medi­cine. 2024;(4):77-83
NDRG1 protein expression in breast cancer samples, rela­tionship with lymph nodes meta­stasis. Russian Journal of Archive of Pathology. 2024;(6):36-42
Impact of tumor size on actuarial survival of patients with primary breast sarcoma: a case-control study. Piro­gov Russian Journal of Surgery. 2024;(12):38-43
Asse­ssment of risk factors for breast cancer deve­lopment in women living in the Sara­tov region. Russian Bulletin of Obstetrician-Gynecologist. 2024;(6):100-106
Left ventricular myocardial performance index (Tei index) as an early marker of cardiotoxicity in anti­tumor therapy. Russian Cardiology Bulletin. 2024;(4-2):137-143
Nottingham Prognostic Index rela­tion to cyto­kine-producing tumor mole­cular subtypes in breast cancer. Russian Journal of Preventive Medi­cine. 2025;(1):63-68
The possibilities of predicting and redu­cing the risk of breast cancer in women against the background of the use of assi­sted reproductive technologies. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):59-64
Abstract:

The paper presents a literature review demonstrating the evolution of treatment in early breast cancer with relatively favorable clinical and morphological features in women over 65 years of age. It details postoperative radiation therapy after organ-sparing surgical treatment and its impact on oncological indicators in patients with Stage I breast cancer in women over 65 years of age.

Keywords:

breast cancer
postoperative radiotherapy
organ-sparing treatment

Authors:

Ortabaeva D.R.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiology Center of the Ministry of Health of Russia

Zikiryakhodzhaev A.D.

I.M. Sechenov First Moscow State Medical University (Sechenov University) of the Ministry of Russia;
P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Russia;
Peoples’ Friendship University of Russia

Rasskazova E.A.

P.A. Herzen Moscow Oncology Research Institute - Branch of the National Medical Radiology Research Center of the Ministry of Health of the Russia

Saribekyan E.K.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Research Radiology Center of the Ministry of Health of Russia

Khmelevsky E.V.

P.A. Herzen Moscow Oncology Research Institute — Branch of the National Medical Radiology Research Center of the Ministry of Health of Russia

Received:

12.02.2021

Accepted:

27.04.2021

Close metadata

References:

  1. Kaprin AD, Starinskii VV, Shakhzadova AO, eds. The state of cancer care in Russia in 2019. M.: MNIOI imeni P.A. Gertsena — filial FGBU «NMITs radiologii» Minzdrava Rossii; 2020. (In Russ.). https://www.oncology.ru/service/statistics/
  2. Inwald EC, Ortmann O, Koller M, Zeman F, Hofstädter F, Evert M, Brockhoff G, Klinkhammer-Schalke M. Screening — relevant age thresh old of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology. Breast Cancer Res Treat. 2017;163(1):119-130.  https://doi.org/10.1007/s10549-017-4151-6
  3. Calculators: life expectancy. Accessed October 9, 2017. www-ssa-gov.ucsf.idm.oclc.org/planners/life expectancy.html
  4. Dimitrakopoulos FI, Kottorou A, Antonacopoulou AG, Makatsoris T, Kalofonos HP. Early-stage breast cancer in the elderly: confronting an old clinical problem. J Breast Cancer. 2015;18(3):207-217.  https://doi.org/10.4048/jbc.2015.18.3.207
  5. Gosain R, Pollock Y, Jain D. Age-related disparity: breast cancer in the elderly. Curr Oncol Rep. 2016;18(11):69.  https://doi.org/10.1007/s11912-016-0551-8
  6. Prakash Pandit, Roshankumar Patil, Vijay Palwe, Sucheta Gandhe, Rahul Patil, Rajnish Nagarkar. Prevalence of molecular subtypes of breast cancer: a single institutional experience of 2062 patients. Eur J Breast Health. 2020;16(1):39-43.  https://doi.org/10.5152/ejbh.2019.4997
  7. Varghese, F, Wong J. Breast cancer in the elderly. Surg Clin N Am. 2018;98(4):819-833.  https://doi.org/10.1016/j.suc.2018.04.002
  8. Mogal HD, Clark C, Dodson R, Fino NF, Howard-McNatt M. Outcomes after mastectomy and lumpectomy in elderly patients with early-stage breast cancer. Ann Surg Oncol. 2017;24(1):100-107.  https://doi.org/10.1245/s10434-016-5582-8
  9. van den Bogaard VA, Ta BD, van der Schaaf A, Bouma AB, Middag AM, Bantema-Joppe EJ, van Dijk LV, van Dijk-Peters FB, Marteijn LA, de Bock GH, Burgerhof JG, Gietema JA, Langendijk JA, Maduro JH, Crijns AP. Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures. J Clin Oncol. 2017;35(11):1171-1178. https://doi.org/10.1200/JCO.2016.69.8480
  10. Wennstig AK, Wadsten C, Garmo H, Fredriksson I, Blomqvist C, Holmberg L, Nilsson G, Sund M. Long-term risk of ischemic heart disease after adjuvant radiotherapy in breast cancer: results from a large population-based cohort. Breast Cancer Res. 2020;22(1):10.  https://doi.org/10.1186/s13058-020-1249-2
  11. NCCN Guidelines Insights: breast cancer. Version 1.2017. 15. 
  12. Cardoso F, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rubio IT, Zackrisson S, Senkus E; ESMO Guidelines Committee. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30(10):1674. https://doi.org/10.1093/annonc/mdz189
  13. Bane AL, Whelan TJ, Pond GR, Parpia S, Gohla G, Fyles AW, Pignol JP, Pritchard KI, Chambers S, Levine MN. Tumor factors predictive of response to hypofractionated radiotherapy in a randomized trial following breast conserving therapy. Ann Oncol. 2014;25(5):992-998.  https://doi.org/10.1093/annonc/mdu090
  14. Franco P, Cante D, Sciacero P, Girelli G, La Porta MR, Ricardi U. Tumor bed boost integration during whole breast radiotherapy: a review of the current evidence. Breast Care (Basel). 2015;10(1):44-49.  https://doi.org/10.1159/000369845
  15. Veronesi U, Salvadori B, Luini A, Banfi A, Zucali R, Del Vecchio M, Saccozzi R, Beretta E, Boracchi P, Farante G, et al. Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg. 1990;211(3):250-259. 
  16. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232. https://doi.org/10.1056/NEJMoa020989
  17. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-year follow-up of a randomized trial comparing total for the treatment of invasive breast cancer. N Engl J Med. 2002;347(16):1233-1241. https://doi.org/10.1056/NEJMoa022152
  18. Anderson SJ, Wapnir I, Dignam JJ, Fisher B, Mamounas EP, Jeong JH, Geyer CE Jr, Wickerham DL, Costantino JP, Wolmark N. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer. J Clin Oncol. 2009;27(15):2466-2473. https://doi.org/10.1200/JCO.2008.19.8424
  19. de Koning HJ, van Dongen JA, van der Maas PJ. Changes in use of breast-conserving therapy in years 1978—2000. Br J Cancer. 1994;70(6):1165-1170. https://doi.org/10.1038/bjc.1994.466
  20. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347(16):1227-1232. https://doi.org/10.1056/NEJMoa020989
  21. Wickberg Å, Magnuson A, Holmberg L, Adami HO, Liljegren G. Influence of the subtype on local recurrence risk of breast cancer with or without radiation therapy. Breast. 2018;42:54-60.  https://doi.org/10.1016/j.breast.2018.08.097
  22. Sjöström M, Lundstedt D, Hartman L, Holmberg E, Killander F, Kovács A, Malmström P, Niméus E, Werner Rönnerman E, Fernö M, Karlsson P. Response to radiotherapy after breast-conserving surgery in different breast cancer Subtypes in the Swedish Breast Cancer Group 91 Radiotherapy Randomized Clinical Trial. J Clin Oncol. 2017;35(28):3222-3229. https://doi.org/10.1200/JCO.2017.72.7263
  23. Hughes KS, Schnaper LA, Bellon JR, Cirrincione CT, Berry DA, McCormick B, Muss HB, Smith BL, Hudis CA, Winer EP, Wood WC. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013;31(19):2382-2387. https://doi.org/10.1200/JCO.2012.45.2615
  24. Fyles AW, McCready DR, Manchul LA, Trudeau ME, Merante P, Pintilie M, Weir LM, Olivotto IA. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med. 2004;351(10):963-970.  https://doi.org/10.1056/NEJMoa040595
  25. Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators. Breast conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015;16(3):266-273.  https://doi.org/10.1016/S1470-2045(14)71221-5
  26. Blamey RW, Bates T, Chetty U, Duffy SW, Ellis IO, George D, Mallon E, Mitchell MJ, Monypenny I, Morgan DA, Macmillan RD, Patnick J, Pinder SE. Radiotherapy or tamoxifen after conserving surgery for breast cancers of excellent prognosis: British Association of Surgical Oncology (BASO) II trial. Eur J Cancer. 2013;49(10):2294-2302. https://doi.org/10.1016/j.ejca.2013.02.031
  27. Liu FF, Shi W, Done SJ, Miller N, Pintilie M, Voduc D, Nielsen TO, Nofech-Mozes S, Chang MC, Whelan TJ, Weir LM, Olivotto IA, McCready DR, Fyles AW. Identification of a low-risk luminal a breast cancer cohort that may not benefit from breast radiotherapy. J Clin Oncol. 2015;33(18):2035-2040. https://doi.org/10.1200/JCO.2014.57.7999
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.